Refine Your Results

Click below to filter your search results

"Infertility"Undo
"Medications or Drugs"Undo

Search Results

Results 1–4 of 4
Sort By: Relevance| Date| Title

Committee Opinion Number 776, April 2019

ABSTRACT: Because autoimmune conditions occur more often among women of childbearing age, continuation of these medications during pregnancy is often considered to optimize disease management in the woman and pregnancy outcomes, without placing the fetus at undue risk. Many commonly prescribed drugs can be used safely during pregnancy without risk of teratogenicity or pregnancy complications, whereas a few are strictly contraindicated. The decision to use any agent during pregnancy should be based on the clinical context, risks associated with individual medications, and gestational age. For ...


Practice Bulletin Number 194, June 2018

(Replaces Practice Bulletin Number 108, October 2009)

Members Only


Committee Opinion Number 605, July 2014

(Reaffirmed 2018)

ABSTRACT: Primary ovarian insufficiency is the depletion or dysfunction of ovarian follicles with cessation of menses before age 40 years. There is no consensus on criteria to identify primary ovarian insufficiency in adolescents, and delay in diagnosis is common. Health care providers who make this clinical diagnosis should be mindful of the sensitive nature of this medical condition. Patients and their families should be counseled on the effect of the patient’s condition on future fertility, on the risk of comorbidities associated with primary ovarian insufficiency, and on the condition’s p...


Practice Bulletin Number 114, July 2010

(Replaces Practice Bulletin Number 11, December 1999) (Reaffirmed 2018)

Members Only


Advertisement

American College of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188
Mailing Address: PO Box 96920, Washington, DC 20024-9998